HomePharmacotherapy sequencing strategies for patients with heart failure with reduced ejection fraction: a cost–utility analysis – CMAJ Pharmacotherapy sequencing strategies for patients with heart failure with reduced ejection fraction: a cost–utility analysis – CMAJCanada Pharmacotherapy sequencing strategies for patients with heart failure with reduced ejection fraction: a cost–utility analysis CMAJ Ensure Adequate Titration of β-Blockers for Optimal Clinical Outcomes in Heart Failure Pharmacy Times